HomeUS StocksREGN

R

Regeneron Pharmaceuticals Inc

REGN Share PriceHealthcare

$ 654.39

29.67 (4.75%)profit
as on 03 Jul 2026 at 01:29 AM

NASDAQ

analyst71.43% Buy
Overview
News
History
Fundamentals
Investment Returns
Financials
Balance Sheet
Cash Flow
Peers
Bulb

As on 03 Jul 2026 01:29 AM Regeneron Pharmaceuticals Inc opened at $630.52 while its previous close was at $624.72. In the trading session REGN reached a high of $654.94 and low of $625.70. The total number of shares traded is 8,11,283. Based on analyst ratings the stock has 71.43% Buy, 0% Sell and 28.57% Hold.

TradingViewarrow

REGN Stock Performance

Markets Today

High

654.94

Low

625.70

Open at

630.52

Prev Close

624.72

Volumes

8,11,283

Price Movement

625.70654.94
4.58%Loss
down side
up side
0.08%Profit

Historical Performance

3 M High

781.21

3 M Low

591.52

1 Yr High

821.11

1 Yr Low

521.00

3 Yr High

1,211.20

3 Yr Low

476.49

5 Yr High

1,211.20

5 Yr Low

476.49

1-Year Performance

521.00821.11
25.60%Loss
down side
up side
20.30%Profit

REGN Analyst Rating

Buy

Analysts have suggested that investors can Buy this Stock

- By ViewTrade from 21 analysts

Buy

71.43%

Hold

28.57%

Sell

0%

REGN Latest News

REGN Share Price History

Close Price

Volume

REGN share price in last 10 trading sessions

DayOpenCloseChange%Day HighDay LowVolume
02 Jul 2026625.94654.39
4.55% profit
654.94624.998,07,188
01 Jul 2026627.25624.80
-0.39% Loss
632.85623.898,20,751
30 Jun 2026636.11623.51
-1.98% Loss
640.22622.295,63,159
29 Jun 2026629.86632.22
0.38% profit
638.30626.865,50,227
26 Jun 2026623.00633.03
1.61% profit
638.76623.006,47,374
25 Jun 2026618.33619.89
0.25% profit
634.44618.335,20,814
24 Jun 2026617.43623.23
0.94% profit
631.48617.434,80,178
23 Jun 2026606.31618.24
1.97% profit
621.79606.316,37,635
22 Jun 2026599.03612.34
2.22% profit
613.56595.248,98,147
18 Jun 2026610.00609.93
-0.01% Loss
616.24598.198,23,033

REGN Fundamentals

Company Valuation

Market Cap

$67,416M

PE Ratio

17.62

PEG Ratio

5.70

PB Ratio

2.42

ROE

14.93%

ROCE

13.08%

REGENERON PHARMACEUTICALS INC Return Calculator

You have invested
Investment Period

Current value of $10,000 invested 5 years ago, as on today

$ 0

Gain

$ 10,000 (13.88%)

Invest Now

Note: Past profits do not guarantee future returns.

REGN Investment Returns

1 Week

1 Month

3 Months

6 Months

REGN Financials Summary

Revenue
EBITDA
Net Profit
EPS
Revenue

In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
3,0293,6763,7543,8843,605

REGN Financials

Income Statement

In USD

Quarterly StatementMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
3,0293,6763,7543,8843,605
Expenses2,4252,5862,6442,9862,861
Operating Profit6041,0901,110899745
Operating Profit Margin %20%30%30%23%21%
Other Income91834-7
7311,2251,2471,044745
Interest30142965314586
Depreciation1271351371450
9051,5191,7631,044831
Tax %11%8%17%19%13%
Net Profit8091,3921,460845727
EPS7131487

Balance Sheet

In USD

Yearly Balance SheetSep 2024Mar 2025Jun 2025Sep 2025Mar 2026
37,44237,54538,21940,16940,869
Fixed Assets4,4394,6944,8415,0025,266
Current Assets19,33417,57216,86017,98118,209
37,44237,54538,21940,16940,869
Share Capital12,70313,19213,49113,78714,401
Reserve & Surplus30,81532,41433,73335,11536,436
Non Current Liabilities4,4554,5914,6134,7874,338
Current Liabilities3,6613,5673,6674,4255,108

Cash Flow

In USD

Quarterly Cash FlowMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Cash from Operating1,0451,1441,6191,1711,079
Cash from Investing648-1,094-403220-429
Cash from Financing-1,089-1,128-718-780-802
Net Cash Flow603-1,078498611-152

REGN Revenue Growth

All values are in USD

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2024-2514,343
0.99% Profit
4,505
2.09% Profit
FY 2023-2414,202
8.27% Profit
4,413
11.61% Profit
FY 2022-2313,117
7.76% Profit
3,954
-8.87% Loss

REGN Similar Stocks

Stock NamePrice
Vertex Pharmaceuticals Inc

V

Vertex Pharmaceuticals Inc

$527.99+6.02%profit
argenx SE

A

argenx SE

$939.75+3.33%profit
Alnylam Pharmaceuticals Inc

A

Alnylam Pharmaceuticals Inc

$312.92+3.73%profit
Revolution Medicines Inc

R

Revolution Medicines Inc

$189.13+0.86%profit
Oncolytics Biotech Inc

O

Oncolytics Biotech Inc

$297.62+2.37%profit

US Indices Today

Index NamePrice
View Allarrow

US Top Gainers Today

Stock NamePrice

US Top Losers Today

Stock NamePrice

What's Trending

What's New In The US Market

Invest in US Stocks with Dhan

Start building a global portfolio from just $1.

4.5 ratings

4.0 ratings

Dhan US Stocks App
logo

Join our Community

community logo

Follow us on

twitter
telegram
Linkedin
youtube
instagram
facebook

built with love
for Indians who love to invest & trade

raise

We are part of Raise Financial Services

raise
raise

Explore  |  Sitemap


*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

We are doing so by giving you access to not just one but 6 products within the Dhan ecosystem:


This means that with Dhan, you'll be able to start:


Lakhs of users already trust Dhan for their online stock trading and investing needs. Dhan is growing rapidly because of the love we receive from SuperTraders and Long-Term Investors who acknowledge that the platform is innovating for them, building super useful features that help them do everything from investing in stock market to trading F&O like a pro on the Tradingview charts and much more.

While we are growing, we will always remember why we started building in the first place - you. Our user-first approach will always be at the heart of our philosophy. Come join us on this incredible journey!

Try it out, you can close your account at anytime using this link.

©2021-2026 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services and works closely with Raise Partners across services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.

Details of client bank account

For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances. You may refer the website https://scores.sebi.gov.in/ for more information. You may also download the SEBI Scores app to log a complaint Android: https://play.google.com store apps sebiscores iOS: https://apps.apple.com app sebiscores.


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Issued in the interest of the investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account. Raise Securities Private Limited (Dhan) does not engage in proprietary trading on its own account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | Investor Charter for Research Analyst | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Grievances RA | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors